论文部分内容阅读
目的比较华法令两种不同初始剂量治疗下肢深静脉血栓的7d安全性及有效性,探讨最佳方案。方法选择符合条件的患者77例,分别按高剂量(初始量5mg/d)和低剂量(初始量2.5mg/d)分组,比较其性别、年龄及体重指数的差异,并进行安全性及有效性分析。结果高剂量组与低剂量组在性别、年龄及体重指数方面差异无统计学意义。安全性方面,高剂量组较低剂量组更易发生停药事件,安全性较低(P<0.05);但两组并发症发生率无差异。有效性方面,高剂量组较低剂量组起效率(P<0.05)和起效时间(P<0.05)均较短,有效性较高;但两组稳定率无差异。结论两种方法在临床应用中各有利弊,但都不是最佳方案,需寻求更好的口服华法令抗凝方案。
Objective To compare the safety and efficacy of two different initial doses of warfarin in the treatment of deep venous thrombosis of the lower extremities for 7 days and to explore the best plan. Methods A total of 77 eligible patients were selected and divided into high dose (initial dose 5mg / d) and low dose (initial dose 2.5mg / d) respectively to compare their gender, age and body mass index, and to evaluate their safety and effectiveness Sexual analysis. Results There was no significant difference in sex, age and body mass index between high-dose group and low-dose group. In terms of safety, the high-dose group was more likely to discontinue the drug than the lower-dose group, with a lower safety (P <0.05). However, there was no difference in the incidence of complications between the two groups. In the aspect of effectiveness, the effective rate (P <0.05) and the onset time (P <0.05) of the high-dose group were shorter and higher than those of the lower dose group, but there was no difference between the two groups. Conclusion Both methods have their advantages and disadvantages in clinical application. However, neither method is the best one, and better oral warfarin oral solution should be sought.